March 8, 2021 Experience PerkinElmer $800 million notes offering We advised the joint bookrunners on the investment-grade debt offering
March 5, 2021 Experience Bristol Myers Squibb debt tender offer We advised the dealer managers on a debt tender offer
March 5, 2021 Experience Heska $175 million follow-on offering We advised the joint book-running managers and underwriters on the equity offering
March 4, 2021 Experience Cigna $4.3 billion senior notes offering We advised the underwriters on the investment-grade debt offering
March 2, 2021 Experience InflaRx $75 million follow-on offering We advised the underwriters on the equity offering
March 1, 2021 Experience Adamas Pharmaceuticals $59 million stock offering We advised the joint book-running managers on the SEC-registered equity offering
March 1, 2021 Experience AVITA Medical $69.1 million follow-on offering We advised the underwriters on the equity offering
March 1, 2021 Experience I-Mab $177 million follow-on secondary offering of ADSs We advised the underwriters on the equity offering
February 26, 2021 Experience JOINN Laboratories HK$6.5 billion IPO We advised JOINN Laboratories on its IPO and HKEX listing.
February 22, 2021 Experience Ayala Pharmaceuticals $25 million private placement We advised the placement agent on the private placement of stock and warrants